About Hawaii Biotech
Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Lead vaccine candidates in clinical development target the West Nile virus and Dengue virus. Additional recombinant protein subunits vaccine candidates produced from this protein production platform are currently under development.
Missing: Hawaii Biotech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Hawaii Biotech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Hawaii Biotech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hawaii Biotech is included in 1 Expert Collection, including Biopharma Tech.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Hawaii Biotech Patents
Hawaii Biotech has filed 1 patent.
Molecular biology, Biotechnology, Proteins, Gene expression, Vaccines
Molecular biology, Biotechnology, Proteins, Gene expression, Vaccines
Latest Hawaii Biotech News
Nov 23, 2022
West Nile Virus Testing Market Market Expectations And Growth Trends Highlighted Until 2029 Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years. Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the West Nile Virus Testing Market . The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2018 along with the key takeaways over the forecast period 2019 to 2029. Request a Sample of this Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10547 The team of analysts at Future Business Insights are focussing on research and market study to produce different West Nile Virus Testing Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the West Nile Virus Testing Market. Key Players The writer will create content on the general strategies of market players. And then will write the key players in the market are: Roche Molecular Systems Inc, Response Biomedical Corp., InBios International, Inc., Cortez Diagnostics Inc, Hawaii Biotech Inc, and CEL-SCI Corporation. Among others. Segmentation The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on: Based on product type West nile virus testing market is further segmented into: Laboratory tests Full in-depth analysis of the parent market The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics. Important changes in market dynamics The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future. Ask the Analyst: https://www.futuremarketinsights.com/askus/rep-gb-10547 Emerging segments and regional markets Queries Solved What is the size of the overall West Nile Virus Testing Market in the Healthcare Industry and its segments? What are the key segments and sub-segments in the market? What are the key drivers, restraints, opportunities, and challenges of the West Nile Virus Testing Market in the Healthcare Industry, and how they are expected to impact the market? What are the attractive investment opportunities within the West Nile Virus Testing Market in the Healthcare Industry? What is the West Nile Virus Testing Market in the Healthcare Industry size at the regional and country-level? What are the key market players focusing on? What are the strategies for growth adopted by the key players in West Nile Virus Testing Market in the Healthcare Industry? What are the recent trends in West Nile Virus Testing Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)? What are the challenges to the West Nile Virus Testing Market in the growth of the Healthcare Industry? What are the key market trends impacting the growth of the West Nile Virus Testing Market in the Healthcare Industry? Top Related Reports Healthcare Market Insights
Hawaii Biotech Web Traffic
Hawaii Biotech Rank
Hawaii Biotech Frequently Asked Questions (FAQ)
When was Hawaii Biotech founded?
Hawaii Biotech was founded in 1982.
Where is Hawaii Biotech's headquarters?
Hawaii Biotech's headquarters is located at 650 Iwilei Road, Suite 204, Honolulu.
What is Hawaii Biotech's latest funding round?
Hawaii Biotech's latest funding round is Loan.
How much did Hawaii Biotech raise?
Hawaii Biotech raised a total of $56.61M.
Who are the investors of Hawaii Biotech?
Investors of Hawaii Biotech include Paycheck Protection Program, National Institute of Allergy and Infectious Diseases, Hawaii Technology Development, Hawaii Angels, William Harris Investors and 6 more.
Who are Hawaii Biotech's competitors?
Competitors of Hawaii Biotech include Aerie, Biolog, Pfenex, Altimmune, AM-Pharma, NGM Biopharmaceuticals, PaxVax, Ascendis Pharma, Variation Biotechnologies, BioVex and 23 more.
Compare Hawaii Biotech to Competitors
Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.
TechnoVax is a privately held biotechnology company and specializes in vaccine development. The company aims to begin clinical trials within the next 18 months.
Etna Biotech headquarters, as well as R&D facilities, are located in Catania, Italy. Currently, the company also has access to R&D and production facilities in Berne, Switzerland. The existing Etna Biotech, focussing on cutting-edge research into viral vectors and virosome-based vaccines, forms the nucleus of a center of excellence in vaccinology with a very promising vaccine pipeline.
Zetra Biologicals is a preclinical stage biopharmaceutical company developing vaccines against pandemic influenza and other infectious diseases.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potential of stem cell therapies. The key technology platforms (ASC-101 and ASC-201) are designed to improve the homing and engraftment of stem cells to target organs and increase their therapeutic potential for cancer patients. Additionally, these platforms have the potential to enhance stem cell treatment of inflammation from chemotherapy/radiation, solid tumors, autoimmune diseases, and ischemic diseases including myocardial infarction and stroke. ASC has strategic partnerships with medical research institutions including the University of Texas M.D. Anderson Cancer Center, the Oklahoma Medical Research Foundation, University of California, the Burnham Institute, Indiana University, Rush Presbyterian and VidaCord Technologia Biomedica.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.